A new study was published earlier this month (July 2017) in the journal Clinical Rheumatology looking at serious adverse events after HPV vaccination. The title of the study is: Serious adverse events after HPV vaccination: a critical review of randomized trials and post-marketing case series. This is an international peer-reviewed journal that has been around since 1945. It is the "Journal of the International League of Associations for Rheumatology," and is the official journal of the Belgian Rheumatology Society. The study was conducted by doctors from the Rheumatology Department and the Immunology Department at the National Institute of Cardiology in Mexico City. The results of their study found: 1. The lack of inert placebo in the vast majority of prelicensure HPV vaccine randomized studies, 2. Large randomized trials disclosed significantly more severe adverse events in the tested HPV vaccine cohort, 3. Pooled safety analysis found more post-immunization symptoms in bivalent HPV vaccine vs. hepatitis A vaccine, 4. Post-marketing HPV vaccine adverse events case series describe similar cluster of symptoms than those reported in pre-clinical trials, 5. The European Medicines Agency report on HPV vaccine safety looked at specific diagnoses and not at symptoms clusters, 6. In-depth analysis of some supportive post-marketing HPV vaccine safety studies discloses disquieting findings. The study found the statistics regarding the new Gardasil 9 particularly troubling, as the statistics suggest that severe harm is suffered every 140 injections, and the number needed to vaccinate in order to see any perceived benefits to the vaccine is 1757. Such a critical study of any vaccine would probably never get published in the United States, as it is considered professional suicide to criticize the extremist position that all vaccines are safe and effective, and that the "science is settled" regarding vaccines.

Read full story...